Nr2c2 | nuclear receptor subfamily 2, group C, member 2
Physiological systems
20 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Mortality/aging
18 No significant impact
4 Not tested
Data collections
Gene metrics:3Significant phenotypes
0Associated diseases
Expression examined in:50Adult tissues
62Embryo tissues
preweaning lethality, incomplete penetrance | 3 supporting datasets | Nr2c2tm1b(EUCOMM)Wtsi | homozygote | Early adult | N/A * | ||
embryonic lethality prior to tooth bud stage | 1 supporting dataset | Nr2c2tm1b(EUCOMM)Wtsi | homozygote | E12.5 | N/A * | ||
impaired glucose tolerance | 1 supporting dataset | Nr2c2tm1b(EUCOMM)Wtsi | heterozygote | Early adult | 4.26x10-5 |
| | | | | | | | | |
External links
No external links available for Nr2c2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Nr2c2tm1(KOMP)Vlcg | Reporter-tagged deletion allele (with selection cassette) | | ES Cell |
Nr2c2tm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell mouse |
Nr2c2tm1b(EUCOMM)Wtsi | Reporter-tagged deletion allele (with selection cassette) | | mouse |
Nr2c2tm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | | ES Cell |